Overcoming the barriers to umbilical cord blood transplantation

References

• Broxmeyer HE, Hangoc G, Cooper S, Ribeiro RC, Graves V, Yoder M, . Growth characteristics and expansion of human umbilical cord blood and estimation of its potential for transplantation in adults. Proc Natl Acad Sci USA. 1992;89:4109–13.
   PubMed Web of Science ®Google Scholar
• Cohen Y, Nagler A. Umbilical cord blood transplantation: how, when and for whom? Blood Rev. 2004;18:167–79.
   PubMed Web of Science ®Google Scholar
• Kurtzberg J, Laughlin M, Graham ML, Smith C, Olson JF, Halperin EC, . Placental blood as a source of hematopoietic stem cells for transplantation into unrelated recipients. N Engl J Med. 1996;335:157–66.
   PubMed Web of Science ®Google Scholar
• Migliaccio AR, Adamson JW, Stevens CE, Dobrila NL, Carrier CM, Rubinstein P. Cell dose and speed of engraftment in placental/umbilical cord blood transplantation: graft progenitor cell content is a better predictor than nucleated cell quantity. Blood. 2000;96:2717–22.
   PubMed Web of Science ®Google Scholar
• Gluckman E, Rocha V, Arcese W, Michel G, Sanz G, Chan KW, . Factors associated with outcomes of unrelated cord blood transplant: guidelines for donor choice. Exp Hematol. 2004;32:397–407.
   PubMed Web of Science ®Google Scholar
• Rubinstein P, Carrier C, Scaradavou A, Kurtzberg J, Adamson J, Migliaccio AR, . Outcomes among 562 recipients of placental-blood transplants from unrelated donors. N Engl J Med. 1998;339:1565–77.
   PubMed Web of Science ®Google Scholar
• Kurtzberg J, Prasad VK, Carter SL, Wagner JE, Baxter-Lowe LA, Wall D, . Results of the Cord Blood Transplantation Study (COBLT): clinical outcomes of unrelated donor umbilical cord blood transplantation in pediatric patients with hematologic malignancies. Blood. 2008;112:4318–27.
   PubMed Web of Science ®Google Scholar
• Martin PL, Carter SL, Kernan NA, Sahdev I, Wall D, Pietryga D, . Results of the cord blood transplantation study (COBLT): outcomes of unrelated donor umbilical cord blood transplantation in pediatric patients with lysosomal and peroxisomal storage diseases. Biol Blood Marrow Transplant. 2006;12:184–94.
   PubMed Web of Science ®Google Scholar
• Sawczyn KK, Quinones R, Malcolm J, Foreman N, Garrington T, Gore L, . Cord blood transplant in childhood ALL. Pediatr Blood Cancer. 2005;45:964–70.
   Google Scholar
• Szabolcs P, Niedzwiecki D. Immune reconstitution after unrelated cord blood transplantation. Cytotherapy. 2007;9:111–22.
   PubMed Web of Science ®Google Scholar
• Thomson BG, Robertson KA, Gowan D, Heilman D, Broxmeyer HE, Emanuel D, . Analysis of engraftment, graft-versus-host disease, and immune recovery following unrelated donor cord blood transplantation. Blood. 2000;96:2703–11.
   PubMed Web of Science ®Google Scholar
• Weinreb S, Delgado JC, Clavijo OP, Yunis EJ, Bayer-Zwirello L, Polansky L, . Transplantation of unrelated cord blood cells. Bone Marrow Transplant. 1998;22:193–6.
   PubMed Web of Science ®Google Scholar
• Barker JN, Weisdorf DJ, DeFor TE, Blazar BR, Miller JS, Wagner JE. Rapid and complete donor chimerism in adult recipients of unrelated donor umbilical cord blood transplantation after reduced-intensity conditioning. Blood. 2003;102:1915–9.
   PubMed Web of Science ®Google Scholar
• De Lima M, St John LS, Wieder ED, Lee MS, McMannis J, Karandish S, . Double-chimaerism after transplantation of two human leucocyte antigen mismatched, unrelated cord blood units. Br J Haematol. 2002;119:773–6.
   PubMed Web of Science ®Google Scholar
• Fernandez MN, Regidor C, Cabrera R, Garcia-Marco J, Briz M, Fores R, . Cord blood transplants: early recovery of neutrophils from co-transplanted sibling haploidentical progenitor cells and lack of engraftment of cultured cord blood cells, as ascertained by analysis of DNA polymorphisms. Bone Marrow Transplant. 2001;28:355–63.
   PubMed Web of Science ®Google Scholar
• Shpall EJ, Quinones R, Giller R, Zeng C, Baron AE, Jones RB, . Transplantation of ex vivo expanded cord blood. Biol Blood Marrow Transplant. 2002;8:368–76.
   PubMed Web of Science ®Google Scholar
• Pecora AL, Stiff P, Jennis A, Goldberg S, Rosenbluth R, Price P, . Prompt and durable engraftment in two older adult patients with high risk chronic myelogenous leukemia (CML) using ex vivo expanded and unmanipulated unrelated umbilical cord blood. Bone Marrow Transplant. 2000;25:797–9.
   PubMed Web of Science ®Google Scholar
• Jaroscak J, Goltry K, Smith A, Waters-Pick B, Martin PL, Driscoll TA, . Augmentation of umbilical cord blood (UCB) transplantation with ex vivo-expanded UCB cells: results of a phase 1 trial using the AastromReplicell System. Blood. 2003;101:5061–7.
   PubMed Web of Science ®Google Scholar
• Pecora AL, Stiff P, LeMaistre CF, Bayer R, Bachier C, Goldberg SL, . A phase II trial evaluating the safety and effectiveness of the AastromReplicell system for augmentation of low-dose blood stem cell transplantation. Bone Marrow Transplant. 2001;28:295–303.
   Google Scholar
• de Lima M, McMannis J, Gee A, Komanduri K, Couriel D, Andersson BS, . Transplantation of ex vivo expanded cord blood cells using the copper chelator tetraethylenepentamine: a phase I/II clinical trial. Bone Marrow Transplant. 2008;41:771–8.
   PubMed Web of Science ®Google Scholar
• Delaney C, Brashem-Stein C, Voorhies H, Gutman J, Dallas M, Heimfeld S . Notch-Mediated Expansion of Human Cord Blood Progenitor Cells Results in Rapid Myeloid Reconstitution in Vivo Following Myeloablative Cord Blood Transplantaion Blood. Blood (ASH Annual Meeting Abstracts) 2008; 112: Abstract 212.
   PubMedGoogle Scholar
• de Lima M, McNiece I, McMannis J, Hosing C, Kebraei P, Komanduri K, . Double Cord Blood Transplantations (CBT) with Ex-vivo expansion (EXP) of one unit utilizing a mesenchymal stromal cell (MSC) Platform. Biology of Blood and Marrow Transplantation 2009;15: No. 2, Supplement, Abstract 122.
   Google Scholar
• Jaing TH, Yang CP, Hung IJ, Chen SH, Sun CF, Chow R. Transplantation of unrelated donor umbilical cord blood utilizing double-unit grafts for five teenagers with transfusion-dependent thalassemia. Bone Marrow Transplant. 2007;40:307–11.
   PubMed Web of Science ®Google Scholar
• Fernandes J, Rocha V, Robin M, de Latour RP, Traineau R, Devergie A, . Second transplant with two unrelated cord blood units for early graft failure after haemato poietic stem cell transplantation. Br J Haematol. 2007;137:248–51.
   PubMed Web of Science ®Google Scholar
• Wang FR, Huang XJ, Zhang YC, Chen YH, Lu DP. Successful transplantation of double unit umbilical-cord blood from unrelated donors in high risk leukemia with a long follow-up. Chin Med J (Engl). 2005;118:772–6.
   Google Scholar
• Tarnani M, Laurenti L, Chiusolo P, Sora F, Innocenti I, Leone G, . Simultaneous double mismatched cord blood transplantation in a young patient with secondary myelodys-plastic syndrome: feasibility and complications. Leuk Lymphoma. 2008;49:821–3.
   PubMed Web of Science ®Google Scholar
• Sarkodee-Adoo C, Alvarnas J, Briggs A, Schriber J, Karanes C, Nademanee A, . Emergency double unrelated umbilical cord blood transplant for acute lymphoblastic leukemia after very late deferral of bone marrow donor. Bone Marrow Transplant. 2008;41:675–6.
   Google Scholar
• Yen HJ, Chiou TJ, Hung GY, Chang CY, Hsieh MY, Tzeng CH, . Long-term mixed full-donor chimerism with dominance reversion after a double-unit cord blood transplant. Eur J Haematol. 2008;80:366–7.
   Web of Science ®Google Scholar
• Majhail NS, Weisdorf DJ, Wagner JE, Defor TE, Brunstein CG, Burns LJ. Comparable results of umbilical cord blood and HLA-matched sibling donor hematopoietic stem cell transplantation after reduced-intensity preparative regimen for advanced Hodgkin lymphoma. Blood. 2006;107:3804–7.
   PubMed Web of Science ®Google Scholar
• Gluckman E, Broxmeyer HA, Auerbach AD, Friedman HS, Douglas GW, Devergie A, . Hematopoietic reconstitution in a patient with Fanconi's anemia by means of umbilical-cord blood from an HLA-identical sibling. N Engl J Med. 1989;321:1174–8.
   PubMed Web of Science ®Google Scholar
• Ballen KK, Barker JN, Stewart SK, Greene MF, Lane TA. Collection and preservation of cord blood for personal use. Biol Blood Marrow Transplant. 2008;14:356–63.
   PubMedGoogle Scholar
• Broxmeyer HE, Douglas GW, Hangoc G, Cooper S, Bard J, English D, . Human umbilical cord blood as a potential source of transplantable hematopoietic stem/progenitor cells. Proc Natl Acad Sci USA. 1989;86:3828–32.
   PubMed Web of Science ®Google Scholar
• Rachamim N, Gan J, Segall H, Krauthgamer R, Marcus H, Berrebi A, . Tolerance induction by ‘megadose’ hematopoietic transplants: donor-type human CD34 stem cells induce potent specific reduction of host anti-donor cytotoxic T lymphocyte precursors in mixed lymphocyte culture. Transplantation. 1998;65:1386–93.
   PubMed Web of Science ®Google Scholar
• Barker JN, Weisdorf DJ, Wagner JE. Creation of a double chimera after the transplantation of umbilical-cord blood from two partially matched unrelated donors. N Engl J Med. 2001;344:1870–1.
   PubMed Web of Science ®Google Scholar
• JN Barker, DJ Weisdorf, TE DeFor, CG Brunstein, JE Wagner. Umbilical cord blood (UCB) transplantation after non-myeloablative (NMA) conditioning for advanced follicular lymphoma, mantle cell lymphoma and chronic lymphocytic leukemia: low transplant-related mortality and high progression-free survival. Blood. 2005;106.
   Google Scholar
• Barker JN, Weisdorf DJ, DeFor TE, Blazar BR, McGlave PB, Miller JS, . Transplantation of 2 partially HLA-matched umbilical cord blood units to enhance engraftment in adults with hematologic malignancy. Blood. 2005;105:1343–7.
   PubMed Web of Science ®Google Scholar
• Ballen KK, Spitzer TR, Yeap BY, McAfee S, Dey BR, Attar E, . Double unrelated reduced-intensity umbilical cord blood transplantation in adults. Biol Blood Marrow Transplant. 2007;13:82–9.
   PubMed Web of Science ®Google Scholar
• Delaney M, Cutler CS, Haspel RL, Yeap BY, McAfee SL, Dey BR, . High-resolution HLA matching in double-umbilical cord blood reduced-intensity transplantation in adults. Transfusion. 2009;49:995–1002.
   Google Scholar
• Haspel RL, Kao G, Yeap BY, Cutler C, Soiffer RJ, Alyea EP, . Preinfusion variables predict the predominant unit in the setting of reduced-intensity double cord blood transplantation. Bone Marrow Transplant. 2008;41:523–9.
   PubMed Web of Science ®Google Scholar
• Lister J, Gryn JF, McQueen KL, Harris DT, Rossetti JM, Shadduck RK. Multiple unit HLA-unmatched sex-mismatched umbilical cord blood transplantation for advanced hematological malignancy. Stem Cells Dev. 2007;16:177–86.
   PubMed Web of Science ®Google Scholar
• JN Barker, A Scaradavou, C Stevens, P Rubinstein. The dose-match interaction in umbilical cord blood (UCB) transplantation: an analysis of the impact of cell dose and HLA-match on the disease free survival (DFS) of 989 patients transplanted with single units for hematological malignancy. Blood. 2007;110:144a.
   Google Scholar
• MR Verneris, C Brunstein, Te DeFor, J Barker, DJ Weisdorf, BR Blazar, JS Miller, JE Wagner, . Risk of relapse (REL) after umbilical cord blood transplantation (UCBT) in patients with acute leukemia: marked reduction in recipients of two units. Blood. 2005;106:93A.
   Google Scholar
• Bradstock K, Hertzberg M, Kerridge I, Svennilson J, George B, McGurgan M, . Single versus double unrelated umbilical cord blood units for allogeneic transplantation in adults with advanced hematological malignancies: a retrospective comparison of outcomes. Intern Med J. 2009 Nov;39(11):744–51.
   Google Scholar
• CG Brunstein, JN Barker, TE DeFor, K French, DJ Weisdorf, JE Wagner . Non-myeloablative (NMA) umbilical cord blood transplantation (UCBT): promising disease-free survival in 95 consecutive patients. Blood. 2005;106.
   Google Scholar
• Williams DA. Ex vivo expansion of hematopoietic stem and progenitor cells: robbing Peter to pay Paul? Blood. 1993;81:3169–72.
   PubMed Web of Science ®Google Scholar
• McNiece IK, Almeida-Porada G, Shpall EJ, Zanjani E. Ex vivo expanded cord blood cells provide rapid engraftment in fetal sheep but lack long-term engrafting potential. Exp Hematol. 2002;30:612–6.
   PubMed Web of Science ®Google Scholar
• Holyoake TL, Alcorn MJ, Richmond L, Farrell E, Pearson C, Green R, . CD34 positive PBPC expanded ex vivo may not provide durable engraftment following myeloablative chemoradiotherapy regimens. Bone Marrow Transplant. 1997;19:1095–101.
   PubMed Web of Science ®Google Scholar
• Purdy MH, Hogan CJ, Hami L, McNiece I, Franklin W, Jones RB, . Large volume ex vivo expansion of CD34-positive hematopoietic progenitor cells for transplantation. J Hematother. 1995;4:515–25.
   PubMedGoogle Scholar
• McNiece I, Jones R, Cagnoni P, Bearman S, Nieto Y, Shpall EJ. Ex-vivo expansion of hematopoietic progenitor cells: preliminary results in breast cancer. Hematol Cell Ther. 1999;41:82–6.
   PubMedGoogle Scholar
• Von Drygalski A, Alespeiti G, Ren L, Adamson JW. Murine bone marrow cells cultured ex vivo in the presence of multiple cytokine combinations lose radioprotective and long-term engraftment potential. Stem Cells Dev. 2004;13:101–11.
   PubMed Web of Science ®Google Scholar
• Lazzari L, Lucchi S, Rebulla P, Porretti L, Puglisi G, Lecchi L, . Long-term expansion and maintenance of cord blood haematopoietic stem cells using thrombo poietin, Flt3-ligand, interleukin (IL)-6 and IL-11 in a serum-free and stroma-free culture system. Br J Haematol. 2001;112:397–404.
   PubMed Web of Science ®Google Scholar
• Filip S, Vavrova J, Vokurkova D, Blaha M, Vanasek J. Myeloid differentiation and maturation of SCF1IL-31IL-11 expanded AC1331/CD341 cells selected from high-risk breast cancer patients. Neoplasma. 2000;47:73–80.
   Google Scholar
• Vavrova J, Filip S, Vokurkova D, Blaha M, Vanasek J, Jebavy L. Ex vivo expansion CD341/AC1331-selected autologous peripheral blood progenitor cells (PBPC) in high-risk breast cancer patients receiving intensive chemotherapy. Hematol Cell Ther. 1999;41:105–12.
   Google Scholar
• Glimm H, Eaves CJ. Direct evidence for multiple self-renewal divisions of human in vivo repopulating hematopoietic cells in short-term culture. Blood. 1999;94:2161–8.
   PubMed Web of Science ®Google Scholar
• Glimm H, Oh IH, Eaves CJ. Human hematopoietic stem cells stimulated to proliferate in vitro lose engraftment potential during their S/G/M transit and do not reenter G. Blood. 2000;96:4185–93.
   PubMed Web of Science ®Google Scholar
• McNiece I, Jones R, Bearman SI, Cagnoni P, Nieto Y, Franklin W, . Ex vivo expanded peripheral blood progenitor cells provide rapid neutrophil recovery after high-dose chemotherapy in patients with breast cancer. Blood. 2000;96:3001–7.
   PubMed Web of Science ®Google Scholar
• McNiece I, Kubegov D, Kerzic P, Shpall EJ, Gross S. Increased expansion and differentiation of cord blood products using a two-step expansion culture. Exp Hematol. 2000;28:1181–6.
   PubMed Web of Science ®Google Scholar
• de Lima M, McMannis JD, Saliba R, Worth L, Kebriaei P, Popat U . Double Cord Blood Transplantation (CBT) with and without Ex-Vivo Expansion (EXP): A Randomized, Controlled Study. Blood (ASH Annual Meeting Abstracts) 2008;112: Abstract 154.
   Google Scholar
• Mohamed AA, Ibrahim AM, El-Masry MW, Mansour IM, Khroshied MA, Gouda HM, . Ex vivo expansion of stem cells: defining optimum conditions using various cytokines. Lab Hematol. 2006;12:86–93.
   PubMedGoogle Scholar
• Piacibello W, Sanavio F, Garetto L, Severino A, Dane A, Gammaitoni L, . Differential growth factor requirement of primitive cord blood hematopoietic stem cell for self-renewal and amplification vs proliferation and differentiation. Leukemia. 1998;12:718–27.
   PubMed Web of Science ®Google Scholar
• Yao CL, Chu IM, Hsieh TB, Hwang SM. A systematic strategy to optimize ex vivo expansion medium for human hematopoietic stem cells derived from umbilical cord blood mononuclear cells. Exp Hematol. 2004;32:720–7.
   PubMed Web of Science ®Google Scholar
• Lazzari L, Lucchi S, Porretti L, Montemurro T, Giordano R, Lopa R, . Comparison of different serum-free media for ex vivo expansion of HPCs from cord blood using thrombopoietin, Flt-3 ligand, IL-6, and IL-11 Transfusion. 2001;41:718–9.
   Google Scholar
• Yao CL, Feng YH, Lin XZ, Chu IM, Hsieh TB, Hwang SM. Characterization of serum-free ex vivo-expanded hematopoietic stem cells derived from human umbilical cord blood CD133(1) cells. Stem Cells Dev. 2006;15:70–8.
   PubMed Web of Science ®Google Scholar
• Peled T, Landau E, Mandel J, Glukhman E, Goudsmid NR, Nagler A, . Linear polyamine copper chelator tetraethylenepentamine augments long-term ex vivo expansion of cord blood-derived CD341 cells and increases their engraftment potential in NOD/SCID mice. Exp Hematol. 2004;32:547–55.
   PubMed Web of Science ®Google Scholar
• Young JC, Wu S, Hansteen G, Du C, Sambucetti L, Remiszewski S, . Inhibitors of histone deacetylases promote hematopoietic stem cell self-renewal. Cytotherapy. 2004;6:328–36.
   PubMed Web of Science ®Google Scholar
• Sato N, Meijer L, Skaltsounis L, Greengard P, Brivanlou AH. Maintenance of pluripotency in human and mouse embryonic stem cells through activation of Wnt signaling by a pharmacological GSK-3-specific inhibitor. Nat Med. 2004;10:55–63.
   PubMed Web of Science ®Google Scholar
• Delaney C, Varnum-Finney B, Aoyama K, Brashem-Stein C, Bernstein ID. Dose-dependent effects of the Notch ligand Delta1 on ex vivo differentiation and in vivo marrow repopulating ability of cord blood cells. Blood. 2005;106:2693–9.
   PubMed Web of Science ®Google Scholar
• Schofield R. The stem cell system. Biomed Pharmacother. 1983;37:375–80.
   PubMed Web of Science ®Google Scholar
• Lemischka IR, Moore KA. Stem cells: interactive niches. Nature. 2003;425:778–9.
   PubMed Web of Science ®Google Scholar
• Fuchs E, Tumbar T, Guasch G. Socializing with the neighbors: stem cells and their niche. Cell. 2004;116:769–78.
   PubMed Web of Science ®Google Scholar
• Allen TD, Dexter TM. The essential cells of the hemopoietic microenvironment. Exp Hematol. 1984;12:517–21.
   PubMed Web of Science ®Google Scholar
• Dexter TM, Coutinho LH, Spooncer E, Heyworth CM, Daniel CP, Schiro R, . Stromal cells in haemopoiesis. Ciba Found Symp. 1990;148:76–95.
   PubMedGoogle Scholar
• Yamazaki K, Roberts RA, Spooncer E, Dexter TM, Allen TD. Cellular interactions between 3T3 cells and interleukin-3-dependent multipotent haemopoietic cells: a model system for stromal-cell-mediated haemopoiesis. J Cell Physiol. 1989;139:301–12.
   PubMed Web of Science ®Google Scholar
• Gartner S, Kaplan HS. Long-term culture of human bone marrow cells. Proc Natl Acad Sci USA. 1980;77:4756–9.
   PubMed Web of Science ®Google Scholar
• Etheridge SL, Spencer GJ, Heath DJ, Genever PG. Expression profiling and functional analysis of wnt signaling mechanisms in mesenchymal stem cells. Stem Cells. 2004;22: 849–60.
   PubMed Web of Science ®Google Scholar
• Kadereit S, Deeds LS, Haynesworth SE, Koc ON, Kozik MM, Szekely E, . Expansion of LTC-ICs and maintenance of p21 and BCL-2 expression in cord blood CD34(1)/CD38(–) early progenitors cultured over human MSCs as a feeder layer. Stem Cells. 2002; 20:573–82.
   PubMed Web of Science ®Google Scholar
• Rattis FM, Voermans C, Reya T. Wnt signaling in the stem cell niche. Curr Opin Hematol. 2004;11:88–94.
   PubMed Web of Science ®Google Scholar
• Majumdar MK, Thiede MA, Haynesworth SE, Bruder SP, Gerson SL. Human marrow-derived mesenchymal stem cells (MSCs) express hematopoietic cytokines and support long-term hematopoiesis when differentiated toward stromal and osteogenic lineages. J Hematother Stem Cell Res. 2000;9: 841–8.
   PubMedGoogle Scholar
• Zhang Y, Li C, Jiang X, Zhang S, Wu Y, Liu B, . Human placenta-derived mesenchymal progenitor cells support culture expansion of long-term culture-initiating cells from cord blood CD341 cells. Exp Hematol. 2004;32:657–64.
   PubMed Web of Science ®Google Scholar
• Yamaguchi M, Hirayama F, Murahashi H, Azuma H, Sato N, Miyazaki H, . Ex vivo expansion of human UC blood primitive hematopoietic progenitors and transplantable stem cells using human primary BM stromal cells and human AB serum. Cytotherapy. 2002;4:109–18.
   PubMed Web of Science ®Google Scholar
• Kanai M, Hirayama F, Yamaguchi M, Ohkawara J, Sato N, Fukazawa K, . Stromal cell-dependent ex vivo expansion of human cord blood progenitors and augmentation of transplantable stem cell activity. Bone Marrow Transplant. 2000;26:837–44.
   PubMed Web of Science ®Google Scholar
• in't Anker PS, Noort WA, Kruisselbrink AB, Scherjon SA, Beekhuizen W, Willemze R, . Nonexpanded primary lung and bone marrow-derived mesenchymal cells promote the engraftment of umbilical cord blood-derived CD34(+) cells in NOD/SCID mice. Exp Hematol. 2003;31:881–9.
   PubMed Web of Science ®Google Scholar
• Noort WA, Kruisselbrink AB, in't Anker PS, Kruger M, van Bezooijen RL, de Paus RA, . Mesenchymal stem cells promote engraftment of human umbilical cord blood-derived CD34(+) cells in NOD/SCID mice. Exp Hematol. 2002;30:870–8.
   PubMed Web of Science ®Google Scholar
• Ahrens N, Tormin A, Paulus M, Roosterman D, Salama A, Krenn V, . Mesenchymal stem cell content of human vertebral bone marrow. Transplantation. 2004;78:925–9.
   PubMedGoogle Scholar
• Le Blanc K, Rasmusson I, Sundberg B, Gotherstrom C, Hassan M, Uzunel M, . Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells. Lancet. 2004;363:1439–41.
   PubMed Web of Science ®Google Scholar
• Gotherstrom C, Ringden O, Tammik C, Zetterberg E, Westgren M, Le Blanc K. Immunologic properties of human fetal mesenchymal stem cells. Am J Obstet Gynecol. 2004;190: 239–45.
   PubMedGoogle Scholar
• Rasmusson I, Ringden O, Sundberg B, Le Blanc K. Mesenchymal stem cells inhibit the formation of cytotoxic T lymphocytes, but not activated cytotoxic T lymphocytes or natural killer cells. Transplantation. 2003;76:1208–13.
   PubMed Web of Science ®Google Scholar
• Zhang J, Niu C, Ye L, Huang H, He X, Tong WG, . Identification of the haematopoietic stem cell niche and control of the niche size. Nature. 2003;425:836–41.
   PubMed Web of Science ®Google Scholar
• McNiece I, Harrington J, Turney J, Kellner J, Shpall EJ. Ex vivo expansion of cord blood mononuclear cells on mesenchymal stem cells. Cytotherapy. 2004;6:311–7.
   PubMed Web of Science ®Google Scholar
• Le Blanc K, Rasmusson I, Gotherstrom C, Seidel C, Sundberg B, Sundin M, . Mesenchymal stem cells inhibit the expression of CD25 (interleukin-2 receptor) and CD38 on phytohaemagglutinin-activated lymphocytes. Scand J Immunol. 2004;60:307–15.
   PubMed Web of Science ®Google Scholar
• De Angeli S, Di Liddo R, Buoro S, Toniolo L, Conconi MT, Belloni AS, . New immortalized human stromal cell lines enhancing in vitro expansion of cord blood hematopoietic stem cells. Int J Mol Med. 2004;13:363–71.
   Google Scholar
• Emerson SG, Palsson BO, Clarke MF, Silver SM, Adams PT, Koller MR, . In vitro expansion of hematopoietic cells for clinical application. Cancer Treat Res. 1995;76:215–23.
   Google Scholar
• Van Zant G, Rummel SA, Koller MR, Larson DB, Drubachevsky I, Palsson M, . Expansion in biore actors of human progenitor populations from cord blood and mobilized peripheral blood. Blood Cells. 1994;20:482–91.
   PubMedGoogle Scholar
• Koller MR, Manchel I, Newsom BS, Palsson MA, Palsson BO. Bioreactor expansion of human bone marrow: comparison of unprocessed, density-separated, and CD34-enriched cells. J Hematother. 1995;4:159–69.
   PubMedGoogle Scholar
• Tsai S, Emerson SG, Sieff CA, Nathan DG. Isolation of a human stromal cell strain secreting hemopoietic growth factors. J Cell Physiol. 1986;127:137–45.
   PubMed Web of Science ®Google Scholar
• Astori G, Adami V, Mambrini G, Bigi L, Cilli M, Facchini A, . Evaluation of ex vivo expansion and engraftment in NOD-SCID mice of umbilical cord blood CD341 cells using the DIDECO ‘Pluricell System’. Bone Marrow Transplant. 2005;35:1101–6.
   PubMed Web of Science ®Google Scholar
• Brunstein CG, Barker JN, Weisdorf DJ, Defor TE, McKenna D, Chong SY, . Intra-BM injection to enhance engraftment after myeloablative umbilical cord blood transplantation with two partially HLA-matched units. Bone Marrow Transplant. 2009;43:935–40.
   PubMed Web of Science ®Google Scholar
• Frassoni F, Gualandi F, Podesta M, Raiola AM, Ibatici A, Piaggio G, . Direct intrabone transplant of unrelated cord-blood cells in acute leukaemia: a phase I/II study. Lancet Oncol. 2008;9:831–9.
   PubMed Web of Science ®Google Scholar
• Dai HS, Gao JT, Zhang TW, Yang Z, Che YZ, Zheng YZ. [Study on the mechanism of enhancing homing efficiency of human hematopoietic stem/progenitor cells into bone marrow after manipulation with tumor necrosis factor alpha in xenotransplanted BALB/c mouse model]. Zhonghua Xue Ye Xue Za Zhi. 2009;30:97–102.
   Google Scholar
• Hao M, Meng HX, Li G, Qi PJ, Xu Y, Li CH, . [Study of influence of umbilical cord mesenchymal stem cells on CD341 cells in vivo homing in NOD/SCID]. Zhonghua Xue Ye Xue Za Zhi. 2009;30:103–6.
   Google Scholar
• Ohno N, Kajiume T, Sera Y, Sato T, Kobayashi M. Short-term culture of umbilical cord blood-derived CD34 cells enhances engraftment into NOD/SCID mice through increased CXCR4 expression. Stem Cells Dev. 2009;18(8):1221–6.
   Google Scholar
• Mazur MA, Davis CC, Szabolcs P. Ex vivo expansion and Th1/Tc1 maturation of umbilical cord blood T cells by CD3/CD28 costimulation. Biol Blood Marrow Transplant. 2008;14:1190–6.
   PubMed Web of Science ®Google Scholar
• Boissel L, Tuncer HH, Betancur M, Wolfberg A, Klingemann H. Umbilical cord mesenchymal stem cells increase expansion of cord blood natural killer cells. Biol Blood Marrow Transplant. 2008;14:1031–8.
   PubMed Web of Science ®Google Scholar